ArticlePloS one2017

HCV kinetic and modeling analyses project shorter durations to cure under combined therapy with daclatasvir and asunaprevir in chronic HCV-infected patients.

Laetitia Canini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.